N/A
N=144
Investigation of Heylo, a Novel App Driven Digital Supporting Ostomy Product
Ileostomy - Stoma · Colostomy Stoma
Bottom Line
View on ClinicalTrials.gov: NCT05200416 ↗Enrolled (actual)
144
Serious AEs
2.4%
Results posted
Jan 2025
Primary outcome: Primary: Emotional Impact Score (Scale From 0-100) — 73.4; 62.0 score on a scale — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Heylo (Device); Standard of Care (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Coloplast A/S
- Primary completion
- Nov 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Emotional Impact Score (Scale From 0-100) |
73.4; 62.0 | <0.001 sig |
| SECONDARY Participation in Society Domain Score (Scale From 0-100) |
33.0; 37.1 | 0.001 sig |
Summary
People with intestinal stomas can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively.
To overcome this, Coloplast has developed a new supporting ostomy product called Heylo™, which has an adhesive sensor layer that should be placed underneath the baseplate. The sensor layer consists of an electronic sensor system that continuously detects moisture and output leakage underneath the baseplate. A transmitter connected to the sensor layer continuously evaluates the incoming information and sends a status to a smartphone software application, which based on a predefined flow decides which information to deliver to the user about the baseplate status.
The overall aim of this clinical investigation is to evaluate the benefits of the new supporting product, Heylo compared to Standard of Care.
Eligibility Criteria
Inclusion Criteria
- Has given written consent to participate by signing the Informed Consent Signature Form.
- Is at least 18 years of age and has full legal capacity.
- Has an ileostomy or colostomy with consistent liquid/mushy fecal output (5-7 Bristol scale*)
- Is able to use one of the five test products (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm).
- Has experienced leakage** under the baseplate at least three times within the last fourteen days. **Leakage defined as output seeping under the baseplate"
- Has worry about leakage to "some degree, high degree, or very high degree" (on a five-point Likert scale: Very low degree/Not at all, Low degree, some degree, High degree, very high degree)
- Is willing to refrain from use of ostomy paste.
- Has a smartphone compatible with the Heylo™ application
- Is able to follow study procedures for 4 months (assessed by investigator or delegate)
Exclusion Criteria
- Is participating in other clinical investigations or has previously participated in this investigation
- Is pregnant or breastfeeding
- Has known hypersensitivity towards any of the products used in the investigation
- Is using/ has a pacemaker
Data sourced from ClinicalTrials.gov (NCT05200416). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.